Sentences with phrase «cell therapy seems»

Our medical team will then carefully review your medical history to determine whether or not adult stem cell therapy seems right for you.

Under these circumstances, the rationale for stem cell therapy seems straightforward: bathe the injury in a healing, concentrated wave of tissue - mending cells, and the body will repair itself that much more quickly.

The potential for stem cell therapy seem limitless at present.

Not exact matches

With cutting - edge techniques from genetics to stem cell therapy - and life - saving drugs to prevent, alleviate or cure conditions like Alzheimer's - likely to be developed in the years ahead, what seem medical miracles today will be medically routine tomorrow.

That fraction might seem low, but it shows that the technique could be used as a model for therapies that replace beta cells in people, the researchers suggest February 18 in Cell Stem Cell.

By performing a genome - wide screen in breast cancer cells, Dr. Oesterreich and her colleagues identified a gene called HOXC10 as one that the cancer seems to modify to allow continued tumor growth in patients whose cancer becomes resistant to traditional therapies.

Stem cells obtained from human embryos seem to offer the best chance of new therapies, because unlike other stem cells they have the ability to morph into almost any type of tissue.

Results showed that not only does anti-androgen receptor therapy reduce the ability of androgen - receptor - expressing triple - negative breast cancers to proliferate, migrate and invade, but for these cells, androgen receptor seems essential to survival.

With so much work needed in studying the nature of stem cells and using them to study disease processes, therapies based on ES cells seem very far down the line, noted Lorenz Studer of Memorial Sloan - Kettering Cancer Center in New York, who pointed out that so far there have only been two published papers on therapeutic cloning, both of them in mice.

Graduate student Megan Radyk and Jason Mills, MD, PhD, led a study revealing that although many cancer therapies target rapidly dividing stem cells, mature cells also seem to play a key role in initiating cancer, at least in forming precancerous lesions.

When he began his Ph.D. work in engineering anti-tumor T cells, gene therapy seemed like the key.